Annexon, Inc.
NASDAQ:ANNXBiotechnology
-$0.04 today
- Market cap
- $576.73M
- Beta
- 1.18
- P/E (TTM)
- -4.8
- EPS (TTM)
- -$1.01
Volume 2.98M
Average 2.56M
ANNX Total Current Liabilities
All obligations due within one year.
Annexon, Inc.NASDAQ: ANNX
Total Current Liabilities · Q1 FY2026 · quarter ended Mar 2026
Total current liabilities rises 7.1% from a year ago
Total current liabilities stood at $35.94M at the end of Q1 FY2026, up 7.1% from a year earlier and down 15.7% from the prior quarter. Over 3 fiscal years it compounded at +24.0% a year.
Context
- Total current liabilities amounted to 13.7% of total assets at the end of Q1 FY2026, up 2.6 pp from a year earlier.
- Total current liabilities increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total current liabilities keeps rising in the next quarterly balance sheet after a +7.1% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 42.63M USD
- Year-over-year change
- +39.7%
- 4-year CAGR
- +18.3%
| Period | Period end | Total Current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 42.63M | +39.7% |
| FY2024 | 2024-12-31 | 30.51M | +70.2% |
| FY2023 | 2023-12-31 | 17.93M | -19.8% |
| FY2022 | 2022-12-31 | 22.36M | +2.8% |
| FY2021 | 2021-12-31 | 21.74M | — |
Total Current Liabilities vs competitors
How ANNX compares with its peers on the latest reported figures
- Peers report in different currencies, so total current liabilities is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +7.1% is the 3rd highest of 11, against a peer median of -12.9%.
- Total current liabilities amounts to 13.7% of total assets for ANNX, versus a peer median of 13.7%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $104.02M USD | +64.5% | +34.1% | 13.7% | |
| Mar 2026 | CHF 92.25M CHF | -7.1% | +102.1% | 67.1% | |
| Jun 2026 | $81.87M USD | -14.8% | +14.5% | 11.3% | |
ALMSAlumis Inc. Common Stock | Jun 2026 | $76.23M USD | -10.9% | +76.4% | 13.6% |
| Jun 2026 | €71.69M EUR | -36.2% | +7.0% | 15.5% | |
| Mar 2026 | $41.7M USD | -5.3% | +14.0% | 12.6% | |
| Mar 2026 | $35.94M USD | +7.1% | +24.0% | 13.7% | |
| Mar 2026 | $32.52M USD | -32.9% | -6.6% | 9.3% | |
| Mar 2026 | $27.37M USD | +27.2% | +9.3% | 13.8% | |
| Mar 2026 | €11.4M EUR | -29.6% | -0.1% | 23.3% | |
| Mar 2026 | $10.67M USD | -26.8% | -41.9% | 16.8% | |
| Peer median (excluding ANNX) | — | -12.9% | +11.7% | 13.7% | |
Competitors are the stored peer set for ANNX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 74.84M | 140.02M | 225.11M | 49.5M | 162.05M |
| Short-term Investments | 167.87M | 102.64M | 34.61M | 262.52M | 76.29M |
| Net Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 463K | 203K | 63K | 1.1M | 1.24M |
| Total Current Assets | 247.69M | 248.1M | 263.86M | 316.46M | 242.19M |
| Property, Plant & Equipment (Net) | 38.18M | 35.97M | 32.78M | 29.34M | 25.8M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 1.03M | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 1.17M | 1.03M | 1.03M | 4.27M | 9.58M |
| Total Non-current Assets | 39.35M | 37M | 33.81M | 33.61M | 35.38M |
| Total Assets | 287.04M | 285.1M | 297.67M | 350.07M | 277.57M |
| Account Payables | 11.15M | 7.42M | 5.49M | 10.43M | 14.93M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 2.06M | 180K | 5.65M | 5.97M | 8.03M |
| Total Current Liabilities | 21.74M | 22.36M | 17.93M | 30.51M | 42.63M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Total Non-current Liabilities | 33.39M | 31.54M | 29.19M | 26.45M | 23.29M |
| Total Liabilities | 55.13M | 53.9M | 47.12M | 56.97M | 65.92M |
| Common Stock | 39K | 48K | 78K | 109K | 149K |
| Retained Earnings | (296.32M) | (438.26M) | (572.5M) | (710.7M) | (917.39M) |
| Accumulated OCI | (180K) | (372K) | (52K) | 10K | (29K) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 231.91M | 231.19M | 250.56M | 293.11M | 211.65M |
| Total Debt | 34.59M | 32.86M | 31.36M | 28.97M | 26.2M |
| Net Debt | (40.25M) | (107.16M) | (193.76M) | (20.53M) | (135.85M) |
Annexon, Inc.
NASDAQ:ANNX
Intrinsic Alpha fair value
Locked
Current Price
$3.52
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.